Connor Maltby

Ulysses Neuroscience Limited
Head of Translational Medicine

Connor Maltby, PhD, earned his PhD in neuroscience-related research and subsequently completed postdoctoral research at the University of Michigan Medical School, where he focused on genetically inherited movement disorders and intellectual disability using human stem cell–derived neuronal models.

Connor’s scientific contributions include publications in peer-reviewed journals focused on synaptic plasticity and stem cell–based translational models. He is actively involved in cross-disciplinary neuroscience research initiatives that integrate cellular and clinical endpoints. Connor earned the NFXF Jr. Investigator award in 2022.

More from the Author

  • NFXF & Programs
  • Premutation Issues
July 7, 2023
12 mins read

At the NFXF’s 18th International Fragile X Conference, we heard insightful discussion regarding the FMR1 premutation from four highly regarded experts whose backgrounds span a diverse range of fields including psychiatry, neurology, basic science, and reproductive biology. Chaired by Hilary Rosselot, questions put forward from the in-person and virtual audiences were discussed and debated by Drs. Randi Hagerman, Deborah Hall, David Hessl, and Emily Allen.